Form 4 for TXG 10x Genomics, Inc.
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-21 · accession 0001610717-24-000530 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-25 | 2024-11-22 | TXG | Saxonov Serge | CEO, Dir | S - Sale | $13.69 | -6,693 | 872.6K | -0.8% | -$91.6K | |
| 2024-11-25 | 2024-11-21 | TXG | Saxonov Serge | CEO, Dir | G - Gift | $0.00 | -1,850 | 879.3K | -0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-22 | S | D | 6,693 | $13.69 | 872,574 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-11-21 | G | D | 1,850 | $0.00 | 879,267 | D | — | — |